Roche Targets Emerging Oncology Market With New Lung-Cancer Drug

The Swiss drugmaker expects a pill it is developing to become the new standard treatment for an advanced form of lung cancer, and the company's first shot at an emerging field within the oncology mark...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。